Ryan Allway March 23rd, 2023 News, Top News VANCOUVER, British Columbia, March 23, 2023 (GLOBE NEWSWIRE) — Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) today announced that the Company has signed a Supply Agreement with MG BioTech Ventures... Read more
Ryan Allway January 23rd, 2023 News, Top News Partnership Will Provide Pharmaceutical Grade Cannabinoid Active Ingredients to the Largest Pharmaceutical and Consumer Goods Names in the Industry BUFFALO, N.Y., Jan. 23, 2023 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with... Read more
Ryan Allway November 14th, 2022 News, Top Story JACKSONVILLE, FL / ACCESSWIRE / November 14, 2022 / LFTD Partners Inc. (“LFTD Partners” or the “Company”) (OTCQB:LIFD), the corporate parent of leading cannabis and psychedelics manufacturer Lifted Made, today reported that it achieved its ninth consecutive quarter of positive earnings per share during the... Read more
Rare Cannabinoid Company Gives Away Free THC + CBC Mood Gummies to Celebrate New Product Launch
October 9, 2022
Ryan Allway October 9th, 2022 News, Top Story Rare Cannabinoid Company announced the launch of their latest product: the world’s first hemp THC gummies with high levels of CBC for improved mood and CBD for the entourage effect. To celebrate, the premium Hawaiian brand is giving away thousands of packets containing... Read more
Top Medical Marijuana Stocks To Buy? 2 Big Pharma Plays In Cannabis
Medical MarijuanaUncategorized September 23, 2022
Could These Be Good Long Term Investments Into Cannabis?
The post Top Medical Marijuana Stocks To Buy? 2 Big Pharma Plays In Cannabis appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Read more
Skye Bioscience Reports that Emerald Health Therapeutics Shareholders Voted in Favor of Plan of Arrangement with Skye
August 21, 2022
San Diego, California, August 19, 2022 — Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the “Company”), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative to treat glaucoma, reports that the shareholders of Emerald Health Therapeutics, Inc. (“Emerald” or the “Company”) (CSE: EMH; OTCQB: EMHTF) today approved the proposed plan of arrangement... Read more
Ryan Allway March 28th, 2022 News, Top News TEL AVIV, Israel and BETHESDA, Md., March 28, 2022 /PRNewswire/ — Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, announced today that it has changed its corporate name to “CNBX Pharmaceuticals Inc.” CNBX Pharmaceuticals The Company’s new... Read more
Initiation of Phase 1 clinical trial of SBI-100 ophthalmic nanemulsion expected in second the quarter of 2022 SAN DIEGO, CA, February 16, 2022 (GLOBE NEWSWIRE) – Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye”), a pharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat diseases with significant unmet need, announced that... Read more
Avicanna Enters into a Strategic Partnership with Tetra Bio-Pharma
February 14, 2022
Ryan Allway February 14th, 2022 News, Top News TORONTO, Feb. 14, 2022 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), an innovative, commercial-stage, and international biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based, cannabinoid-based products, is pleased to announce... Read more
It’s National CBD Month!
CBDUncategorized January 19, 2022
It’s National CBD Month! As legalization rapidly expands across the globe, CBD has become just as popular as THC. Here are 4 things to know to help you choose the right product.
The post It’s National CBD Month! appeared first on The Cannifornian.
Read more
